Everpar Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
SP
CRM
SW
AWA
SFA
HPC
Everpar Advisors's AMGN Position: Q2 2026 in Review
Everpar Advisors reduced its Amgen (AMGN) stake by 1.2% in Q2 2026, selling an estimated $8.9K and leaving 2,218 shares worth $803K. The position accounts for 0.23% of the portfolio, ranked #92.
Everpar Advisors first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.16M in Q4 2023. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Everpar Advisors held 2,218 shares of Amgen worth $803K as of Q2 2026.
- Everpar Advisors sold 26 Amgen shares in Q2 2026, an estimated $8.9K.
- Amgen made up 0.23% of Everpar Advisors's portfolio in Q2 2026, its #92 holding.
- Everpar Advisors first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
- Everpar Advisors's Amgen position peaked at $1.16M in Q4 2023.
- 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Everpar Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.